HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chemical Firm Ceases Phthalate Production, Signaling Market Scale-Down

This article was originally published in The Rose Sheet

Executive Summary

In a move applauded by the Campaign for Safe Cosmetics (CSC), a large phthalates producer, Eastman Chemical Company, has announced it will cease manufacturing two phthalate plasticizers in favor of alternative ingredients.

You may also be interested in...



EC/REACH Bans Six Substances, Including Musk Xylene And Three Phthalates

Acting under Registration, Evaluation, Authorization and Restriction of Chemicals law, the European Commission has published its first group of substances to be phased out by 2015.

EPA Action Plan For Phthalates Could Lead To Restrictions In 2012

The Environmental Protection Agency has issued an action plan for eight phthalates, including two used in cosmetics, which could lay the groundwork for a large-scale ban of the substances in 2012

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017504

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel